The global urine monitoring systems market was estimated to gain a market valuation of US$ 523.4 Million in the year 2022. With a rapidly increasing CAGR of 9.2% during the forecast period of 2023 to 2033, this market is expected to garner US$ 571.55 Million by 2023 and US$ 1378.11 Million by 2033.
Due to factors including the increased prevalence of disorders like diabetes, renal disease, as well as urinary tract infections (UTIs), the market for urine monitoring systems is expanding. The increased use of automated and sophisticated In the United States, around 34.5 million people aged 18 and older have diabetes, according to the National Diabetes Statistical Report, 2020. Due to elevated blood sugar along with high blood pressure, around one-third of persons with diabetes also have kidney-related complications. Clinicians can use urine monitoring devices, a useful and non-invasive diagnostic technique, to identify renal illness. As a result, it is projected that the increased incidence of renal illnesses would boost demand for urine monitoring products and propel market expansion.
Key competitors in the urine monitoring systems market may anticipate future development prospects in developing nations like South Korea, India, Brazil, and Mexico. The number of chronic illnesses is growing, the healthcare system has improved, there are many patients, and people have more disposable cash. For instance, India saw a rise in healthcare spending from 232.65 million USD in 2020 to 507.87 million USD in 2021.
The goal of government screening programmes is to identify diseases like renal as well as urinary abnormalities early. For example, under school urine analysis programmes, 12,487 kids from elementary and secondary schools in Cangnan, Pingyang, and Yongjia in China, were checked for urinalysis. Among elementary and secondary school kids, urine anomalies were detected at a rate of 36.1% and 95.2%, respectively. With the expansion of these initiatives, it is projected that demand for urine monitoring devices would rise.
The category is growing as a result of rising investments in the creation of urine monitoring kits for use at home in the diagnosis of diseases. For example, Vivoo funded a sum of US$ 6 million in the year 2021 to launch at-home urine monitoring that offers dietary and lifestyle advice. For routine urine monitoring system testing, emerging countries with high-price sensitivity favored affordable but similarly functional analyzers. Thus, the creation of inexpensive urine monitoring systems is expected to drive market expansion.
In 2022, North America led the market and contributed 36.5% of total sales. Its dominance might be due to strategic actions done by important participants, like licensing deals to increase corporate presence. For instance, Sysmex along with Siemens Healthcare GmbH entered into an exclusive license arrangement in 2020 to market and support the automatic urine monitoring device CLINITEK Novus to hospitals and referred laboratories in North America. The market will increase as a result of this deal.
The major market participants want to provide ground-breaking products that will improve the efficacy of urine analysis. The SensicaTM Urine Output System, for instance, is an automatic urine output monitoring device for bedside tracking of any patient with a typical BardTM Foley catheter and drainage system. When attached to a temperature-sensing Foley catheter, the device continually measures urine production and core bladder temperature and may send information immediately into the person's electronic medical record (EMR). BD's EMR Interoperability solution, which is available for an extra cost, must be used to link the SensicaTM Urine Output System to the EMR for this functionality to be used. Revenues in this market are thus anticipated to increase between 2023 and 2033 as a result of such advancements.
Data Point | Key Statistics |
---|---|
Expected Market value in 2023 | US$ 571.55 Million |
Expected Market value in 2033 | US$ 1378.11 Million |
Growth Rate (2023 to 2033) | 9.2% from 2023 to 2033 |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Urine monitoring systems are used for monitoring urine output, including both volume and flow rate, either manually or automatically. Urine monitoring systems continuously monitor urine output and are believed to save time and reduce the workload of the healthcare staff.
Urine monitoring systems use a capacitive sensor for the measurement of urine output collected within a rigid container, the volume and flow rate is then used for determining any abnormality. Urine monitoring systems are widely used in the management of kidney disorders. The market of urine monitoring systems is likely to expand during the forecast period with the increasing demand for efficient management of kidney disorders.
The outbreak of novel coronavirus is believed to have a severe impact on the global urine monitoring systems market. There has been a disruption in the import of raw materials that are required in the production of Urine monitoring systems.
Urine monitoring systems manufacturing industries are being shuttered around the world causing an unprecedented technology and business model transformation. The flow of patients in hospitals and clinics during COVID-19 has fallen, leading to the decreased demand for the management of kidney disorders.
After the supply and manufacturing disruptions, the industries are now facing a demand shock with an uncertain recovery timeline due to shelter-in-place regulations.
The increasing prevalence of kidney disorders across the globe and the increased focus of healthcare providers on the effective management of kidney disorders are the major factors driving the growth of the urine monitoring systems market.
In 2017, the National Chronic Kidney Disease Fact Sheet stated, around 30 million of the USA population were suffering from form kidney disorders, which is nearly 15% of the USA population. The demand for minimally invasive and effective systems to monitor patients’ urine output in neonatal care units is increasing which is also expected to drive the urine monitoring systems market.
Also, the rising adoption of the urine monitoring systems market by hospitals and specialty clinics is likely to boost the urine monitoring systems market. However, the risk of getting urinary tract infections, and false odor are some of the factors that hamper the growth of the urine monitoring systems market.
Based on the product type, the automatic segment is expected to hold a major share of the urine monitoring systems market. Based on the usage, the reusable segment is expected to dominate the urine monitoring systems market. Based on the end-user, the hospital segment is expected to be the most profitable segment in the urine monitoring systems market due to the higher patient flow and advanced medical facilities in the hospital.
North America is expected to dominate the global urine monitoring systems market, due to the increasing prevalence of chronic kidney disorders in the region, and the higher adoption of urine monitoring systems in hospitals and clinics.
North America is expected to be followed by Europe, due to the increasing number of new products introduced by the manufacturers in the region. Asia-Pacific is expected to have significant growth in the global urine monitoring systems market over the forecast period due to the increasing number of patients suffering from kidney disorders.
Also, the increasing geriatric population is further likely to expand the urine monitoring systems in countries like China and India.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the market participants in the global urine monitoring systems market identified across the value chain include:
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis and Forecast 6.1. Product Type 6.2. Usage 6.3. End-User 7. Global Market Analysis and Forecast, By Product Type 7.1. Manual 7.2. Automatic 8. Global Market Analysis and Forecast, By Usage 8.1. Disposable 8.2. Reusable 9. Global Market Analysis and Forecast, By End-User 9.1. Hospitals 9.2. Specialty Clinics 9.3. Others 10. Global Market Analysis and Forecast, By Region 10.1. North America 10.2. Western Europe 10.3. Asia Pacific 10.4. China 10.5. Japan 10.6. Middle East and Africa 11. North America Sales Analysis and Forecast, by Key Segments and Countries 12. Western Europe Sales Analysis and Forecast, by Key Segments and Countries 13. Asia Pacific Sales Analysis and Forecast, by Key Segments and Countries 14. China Sales Analysis and Forecast, by Key Segments and Countries 15. Japan Sales Analysis and Forecast, by Key Segments and Countries 16. Middle East and Africa Sales Analysis and Forecast, by Key Segments and Countries 17. Sales Forecast by Product Type, Usage, and End-User for 30 Countries 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 19. Company Profile 19.1. Degania Silicone Ltd. 19.2. Cardinal Health Inc. 19.3. Navamedic ASA 19.4. Future Path Medical Holding Company LLC 19.5. RenalSense Ltd. 19.6. Potrero Medical Inc. 19.7. Roche Holding AG 19.8. Patricia Industries 19.9. Medispec Ltd 19.10. SCHIPPERS-MEDIZINTECHNIK
Explore Healthcare Insights
View Reports